Prolonged Hypogammaglobulinemia Following Rituximab Treatment for Non-Hodgkin's Lymphoma Disease

被引：0

作者：

Hannouch, Kristine ^{[1
]}

McGoey, Barbara ^{[1
]}

Michelis, Mary Ann ^{[1
]}

机构：

[1] Hackensack Univ Med Ctr, Ctr Allergy Asthma & Immune Disorders, Hackensack, NJ USA

来源：

JOURNAL OF CLINICAL IMMUNOLOGY | 2012年 / 32卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：385 / 385

页数：1

共 50 条

[1] Rituximab in the treatment of non-Hodgkin's lymphoma
Hauptrock, Beate
Hess, Georg
BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 619 - 633
[2] Rituximab combinations in the treatment of non-Hodgkin's lymphoma
Leonard, John P.
CANCER INVESTIGATION, 2007, 25 : 43 - 44
[3] The preclinical discovery of rituximab for the treatment of non-Hodgkin's lymphoma
Smolewski, Piotr
Robak, Tadeusz
EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (07) : 791 - 808
[4] Systemic lupus erythematosus following rituximab treatment for non-Hodgkin lymphoma
Soura, Efthymia
Avgerinou, Georgia
Papoutsaki, Marina
Stavropoulos, Panagiotis
Antoniou, Christina
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (03): : 298 - 301
[5] Rituximab for the therapy of non-Hodgkin's lymphoma
Rummel, M. J.
ONKOLOGE, 2007, 13 (03): : 227 - +
[6] Rituximab immunotherapy for non-Hodgkin's lymphoma
White, CA
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1999, 14 (04) : 241 - 250
[7] Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma
J Shortt
A Spencer
Bone Marrow Transplantation, 2006, 38 : 433 - 436
[8] Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma
Shortt, J.
Spencer, A.
BONE MARROW TRANSPLANTATION, 2006, 38 (06) : 433 - 436
[9] Rituximab for the Treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia
Fredrick Hagemeister
Drugs, 2010, 70 : 261 - 272
[10] Rituximab for the Treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia
Hagemeister, Fredrick
DRUGS, 2010, 70 (03) : 261 - 272

← 1 2 3 4 5 →